Andy C. Rawstron

Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma: A Meta-analysis

N. Munshi, W. Gregory, M. Samur, 2017, JAMA oncology.

Analysis of CD34+ cell subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34+ cell dose, but steady state levels do not correlate with bone marrow reserve

R. Johnson, G. Pratt, G J Morgan, 2001, British journal of haematology.

Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis.

Gonzalez, W. Wong, G. Morgan, 2003, Blood.